Embolization Coils Market Report 2024

The embolization coils market size has grown steadily in recent years. It will grow from $1.37 billion in 2023 to $1.44 billion in 2024 at a compound annual growth rate (CAGR) of 4.6%. The growth in the historic period can be attributed to several factors, increasing prevalence of neurovascular disorders, a rising geriatric population, growing demand for minimally invasive procedures, improvements in healthcare infrastructure, and increasing healthcare expenditure.

The embolization coils market size is expected to see steady growth in the next few years. It will grow to $1.73 billion in 2028 at a compound annual growth rate (CAGR) of 4.7%. The growth expected during the forecast period is due to several factors, the increasing use of these technologies in emerging markets, the advancement of new embolization methods, heightened awareness of neurovascular conditions, the growing incidence of chronic diseases, and greater investments in research and development. Key trends anticipated in the forecast period include personalized treatment methods, the integration of artificial intelligence into treatment planning, the introduction of advanced embolic materials, a move towards outpatient and ambulatory procedures, and a focus on patient-centered care.

The increasing prevalence of chronic illnesses is anticipated to drive the growth of the embolization coils market in the future. This rise in chronic illnesses is primarily attributed to aging populations and lifestyle factors such as poor diet, lack of physical activity, and increased stress. Furthermore, advancements in diagnostics and longer life expectancies contribute to the higher number of reported cases. Embolization coils are used in treating chronic illnesses such as coronary artery aneurysms and fistulas by occluding these abnormal connections, thus preventing complications such as rupture. For example, a report published in August 2022 by the American College of Cardiology, a US-based non-profit medical association, projected that in the United States, all four major cardiovascular risk factors will increase from 2025 to 2060. Diabetes is expected to see the largest percentage rise, with a 39.3% increase to 55 million individuals, followed by dyslipidemia (27.6% to 126 million), hypertension (25.1% to 162 million), and obesity (18.3% to 126 million). Therefore, the increase in the prevalence of chronic illnesses is expected to drive the growth of the embolization coils market.

Leading companies in the embolization coils market are developing innovative products, such as fibered detachable coils, to offer advanced features to their customers. A fibered detachable coil is a type of embolization coil used in minimally invasive procedures to obstruct or reduce blood flow in blood vessels. For instance, in April 2022, Boston Scientific Corporation, a US-based manufacturer of medical devices, announced the U.S. Food and Drug Administration (FDA) approval for the EMBOLD fibered detachable coil. It is designed to block or decrease blood flow in the peripheral blood vessels and is intended for use in a variety of embolization procedures, which are minimally invasive treatments meant to block one or more blood vessels to obstruct or reduce blood flow. This technique is used to stop hemorrhaging, prevent aneurysm ruptures, reduce the size of certain tumors, and treat various venous abnormalities.

In November 2023, The Cooper Companies Inc., a US-based medical device company, acquired select Cook Medical assets for $300 million. This acquisition strengthens CooperSurgical's medical device portfolio and enhances its market position. Cook Medical is a US-based manufacturer of embolization coils.

Major companies operating in the embolization coils market are Johnson & Johnson Services Inc., Abbott Laboratories Inc., Medtronic Plc, Heraeus Holding, Stryker Corporation, Boston Scientific Corporation, Terumo Corporation, Kaneka Corporation, Cook Medical LLC, Integer Holdings Corporation, MicroPort Scientific Corporation, Penumbra Inc., Guerbet LLC, Asahi Intecc Co. Ltd., MicroVention Inc., Balt USA LLC, InNeuroCo Inc., Wallaby Medical Inc., Rapid Medical Ltd., Spartan Micro Inc., QXMedical LLC, EmbolX Inc., Shape Memory Medical Inc., Blockade Medical LLC, Achieva Medical Co.

North America was the largest region in the embolization coils market in 2023. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the embolization coils market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the embolization coils market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Embolization coils are small metallic devices used in medical procedures known as embolization, aimed at obstructing or reducing blood flow to specific areas of the body. They are crucial in treating conditions such as brain aneurysms, arteriovenous malformations (AVMs), and arteriovenous fistulas by occluding blood vessels and preventing potential rupture or bleeding.

The main types of embolization coils include detachable coils and pushable coils. Detachable embolization coils are utilized in interventional radiology for treating aneurysms and other vascular abnormalities. They are typically composed of materials such as platinum, platinum with hydrogel, or platinum tungsten alloy. These coils find applications in neurology, urology, peripheral vascular disease, oncology, cardiology, and other medical fields. They are used by various end-users including hospitals, ambulatory centers, cardiovascular centers, and others.

The embolization coils market research report is one of a series of new reports that provides embolization coils market statistics, including embolization coils industry global market size, regional shares, competitors with a embolization coils market share, detailed embolization coils market segments, market trends and opportunities, and any further data you may need to thrive in the embolization coils industry. This embolization coils market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The embolization coils market consists of sales of bare metal coils, fibered coils, micro coils, and liquid embolics. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.